{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:21:54Z","timestamp":1777922514318,"version":"3.51.4"},"reference-count":55,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p>This Long-Covid disease, mild or severe, is multiorgan or system-wide, spanning from fatigue to clotting abnormalities and autoantibody. The spectrum of different symptoms in Long-Covid diseases makes it difficult to point to a common immunopathogenic etiology. Different immune pathways are presented and critically evaluated. A hypothesis is advanced that indicates autoimmune reactions as cause for Long-Covid disease. The immune network pathway describes a redirection of the nominal anti-SARS-CoV response towards an autoimmune target. Several therapeutic interventions are suggested to suppress the autoimmune pathway.<\/jats:p>","DOI":"10.1089\/mab.2024.0006","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T05:12:33Z","timestamp":1725858753000},"page":"131-134","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune Jumping in Autoimmune Long-Covid"],"prefix":"10.1177","volume":"43","author":[{"given":"Heinz","family":"Kohler","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Kentucky, Lexington, Kentucky, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2023.01.006"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00904-7"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102146"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40460-1"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000418"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj090"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28273"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103070"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.9.2701"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.135.6.1293"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.12.5083"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830060208"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.150.4.808"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.129.1.139"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1993.tb05965.x"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500623"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6505692"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109084"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2020.0044"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.698169"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202300071"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158288"},{"issue":"2","key":"e_1_3_3_24_2","article-title":"Anti-idiotypic agonistic antibodies: Candidates for the role of universal remedy","volume":"9","author":"Stanova AK","year":"2020","unstructured":"Stanova AK, , Ryabkova VA, , Utekhin SV, et al. Anti-idiotypic agonistic antibodies: Candidates for the role of universal remedy. Antibodies (Basel), 2020; 9(2); doi: 10.3390\/antib9020019","journal-title":"Antibodies (Basel)"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106464"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2020.1713153"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190446"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01471"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-3461-0_16"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.724654"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2412"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1357825"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-02191-z"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.156.3.860"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(86)90189-9"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(85)90103-6"},{"issue":"1","key":"e_1_3_3_37_2","first-page":"24","article-title":"The response to phosphorylcholine: Dissecting an immune response","volume":"27","author":"Kohler H","year":"1975","unstructured":"Kohler H. The response to phosphorylcholine: Dissecting an immune response. Transplant Rev, 1975; 27(1):24\u201356.","journal-title":"Transplant Rev"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1982.tb01154.x"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.10.2616"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmaa044"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2020.0041"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00106"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.09.021"},{"issue":"1","key":"e_1_3_3_44_2","first-page":"373","article-title":"Towards a network theory of the immune system","volume":"125","author":"Jerne NK","year":"1974","unstructured":"Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris), 1974; 125C(1\u20132):373\u2013389.","journal-title":"Ann Immunol (Paris)"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00196"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00808"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2023.12.017"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2023.115842"},{"issue":"9","key":"e_1_3_3_49_2","first-page":"898","article-title":"Anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. Reply","volume":"386","author":"Murphy WJ","year":"2022","unstructured":"Murphy WJ, , Longo DL. Anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. Reply. N Engl J Med, 2022; 386(9):898\u2013899; doi: 10.1056\/NEJMc2119443","journal-title":"N Engl J Med"},{"issue":"4","key":"e_1_3_3_50_2","article-title":"Expanding the Anti-Phl p 7 antibody toolkit: An anti-idiotype nanobody inhibitor","volume":"12","author":"Vester SK","year":"2023","unstructured":"Vester SK, , Davies AM, , Beavil RL, et al. Expanding the Anti-Phl p 7 antibody toolkit: An anti-idiotype nanobody inhibitor. Antibodies (Basel), 2023; 12(4); doi: 10.3390\/antib12040075","journal-title":"Antibodies (Basel)"},{"issue":"9","key":"e_1_3_3_51_2","first-page":"898","article-title":"Anti-idiotype antibodies in SARS-CoV-2 infection and vaccination","volume":"386","author":"Harville TO","year":"2022","unstructured":"Harville TO, , Arthur JM. Anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. N Engl J Med, 2022; 386(9):898; doi: 10.1056\/NEJMc2119443","journal-title":"N Engl J Med"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41231-021-00097-y"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e57"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02207.x"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0003"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00011"}],"container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mab.2024.0006","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2024.0006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2024.0006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:22:31Z","timestamp":1777666951000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/mab.2024.0006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10,1]]}},"alternative-id":["10.1089\/mab.2024.0006"],"URL":"https:\/\/doi.org\/10.1089\/mab.2024.0006","relation":{},"ISSN":["2167-9436","2167-9436"],"issn-type":[{"value":"2167-9436","type":"print"},{"value":"2167-9436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}